Cascadian Therapeutics' IPO

Cascadian Therapeutics raised a round of funding on November 30, 1991. Investors include Public.

Cascadian Therapeutics, fka Oncothyreon, is a clinical-stage biopharmaceutical company dedicated to developing innovative product candidates for the treatment of cancer.…

Articles about Cascadian Therapeutics' IPO: